CBSET, Inc. is a not for profit company dedicated to the advancement of science, research, and education in the areas of cardiovascular medicine and treatment of various complex disease states. CBSET provides high-quality in-vivo, non-clinical GLP and non-GLP studies to companies developing novel medical devices or therapeutic compounds. Whether in early stage prototype validation or looking to run a GLP pivotal study for submission to the FDA, CBSET can provide exceptional expertise to guiding you through the process.
CBSET’s facilities are located in Lexington MA and include the most current “Clinical Grade” interventional and surgical facilities, state of the art imaging technologies, pre-clinical in-vivo capabilities, numerous ex-vivo diagnostic techniques, and complex computer modeling.
CBSET combines expert clinical and engineering expertise with novel pre-clinical models to drive better and more comprehensive assessment of the mechanisms of disease. Through publication of scientific data, CBSET will advance the education and improve the understanding of the integrated and mechanistic disease states.